Bakshi RP - Search Results

1

Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito.

Balta VA, Stiffler D, Sayeed A, Tripathi AK, Elahi R, Mlambo G, Bakshi RP, Dziedzic AG, Jedlicka AE, Nenortas E, Romero-Rodriguez K, Canonizado MA, Mann A, Owen A, Sullivan DJ, Prigge ST, Sinnis P, Shapiro TA. Balta VA, et al. Among authors: bakshi rp. Nat Commun. 2023 Oct 12;14(1):6415. doi: 10.1038/s41467-023-42030-x. Nat Commun. 2023. PMID: 37828012 Free PMC article.

2

DNA topoisomerases as targets for antiprotozoal therapy.

Bakshi RP, Shapiro TA. Bakshi RP, et al. Mini Rev Med Chem. 2003 Sep;3(6):597-608. doi: 10.2174/1389557033487863. Mini Rev Med Chem. 2003. PMID: 12871162 Review.

3

RNA interference of Trypanosoma brucei topoisomerase IB: both subunits are essential.

Bakshi RP, Shapiro TA. Bakshi RP, et al. Mol Biochem Parasitol. 2004 Aug;136(2):249-55. doi: 10.1016/j.molbiopara.2004.04.006. Mol Biochem Parasitol. 2004. PMID: 15478803

4

Activity of indenoisoquinolines against African trypanosomes.

Bakshi RP, Sang D, Morrell A, Cushman M, Shapiro TA. Bakshi RP, et al. Antimicrob Agents Chemother. 2009 Jan;53(1):123-8. doi: 10.1128/AAC.00650-07. Epub 2008 Sep 29. Antimicrob Agents Chemother. 2009. PMID: 18824603 Free PMC article.

5

Phase I/II evaluation of the prophylactic antimalarial activity of pafuramidine in healthy volunteers challenged with Plasmodium falciparum sporozoites.

Nyunt MM, Hendrix CW, Bakshi RP, Kumar N, Shapiro TA. Nyunt MM, et al. Among authors: bakshi rp. Am J Trop Med Hyg. 2009 Apr;80(4):528-35. Am J Trop Med Hyg. 2009. PMID: 19346370 Free PMC article. Clinical Trial.

6

Membrane active chelators as novel anti-African trypanosome and anti-malarial drugs.

Grab DJ, Nenortas E, Bakshi RP, Nikolskaia OV, Friedman JE, Shapiro TA. Grab DJ, et al. Among authors: bakshi rp. Parasitol Int. 2013 Oct;62(5):461-3. doi: 10.1016/j.parint.2013.06.009. Epub 2013 Jun 28. Parasitol Int. 2013. PMID: 23811202 Free PMC article.

7

Model system to define pharmacokinetic requirements for antimalarial drug efficacy.

Bakshi RP, Nenortas E, Tripathi AK, Sullivan DJ, Shapiro TA. Bakshi RP, et al. Sci Transl Med. 2013 Oct 2;5(205):205ra135. doi: 10.1126/scitranslmed.3006684. Sci Transl Med. 2013. PMID: 24089407 Free PMC article.

8

Hollow-Fiber Methodology for Pharmacokinetic/Pharmacodynamic Studies of Antimalarial Compounds.

Caton E, Nenortas E, Bakshi RP, Shapiro TA. Caton E, et al. Among authors: bakshi rp. Curr Protoc Chem Biol. 2016 Mar 16;8(1):29-58. doi: 10.1002/9780470559277.ch150194. Curr Protoc Chem Biol. 2016. PMID: 26995353 Free PMC article.

9

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis.

Bakshi RP, Tatham LM, Savage AC, Tripathi AK, Mlambo G, Ippolito MM, Nenortas E, Rannard SP, Owen A, Shapiro TA. Bakshi RP, et al. Nat Commun. 2018 Jan 22;9(1):315. doi: 10.1038/s41467-017-02603-z. Nat Commun. 2018. PMID: 29358624 Free PMC article.

10

Kinetic Driver of Antibacterial Drugs against Plasmodium falciparum and Implications for Clinical Dosing.

Caton E, Nenortas E, Bakshi RP, Shapiro TA. Caton E, et al. Among authors: bakshi rp. Antimicrob Agents Chemother. 2019 Oct 22;63(11):e00416-19. doi: 10.1128/AAC.00416-19. Print 2019 Nov. Antimicrob Agents Chemother. 2019. PMID: 31451506 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page